CADIAN CAPITAL MANAGEMENT, LP - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 142 filers reported holding INTERSECT ENT INC in Q3 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
CADIAN CAPITAL MANAGEMENT, LP ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q3 2018$9,617,000
-23.2%
334,5140.0%0.44%
-27.5%
Q2 2018$12,528,000
+26.1%
334,514
+32.3%
0.60%
+12.3%
Q1 2018$9,933,000
+267.9%
252,757
+110.6%
0.54%
+453.6%
Q4 2015$2,700,000
-3.8%
120,0000.0%0.10%
-4.0%
Q3 2015$2,808,000120,0000.10%
Other shareholders
INTERSECT ENT INC shareholders Q3 2018
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 238,698$3,781,0003.74%
PURA VIDA INVESTMENTS, LLC 275,000$4,356,0001.32%
Broadfin Capital, LLC 638,600$10,115,0000.91%
Aisling Capital LLC 248,498$3,936,0000.81%
Bellevue Group AG 205,325$3,252,0000.59%
Iguana Healthcare Management, LLC 180,000$2,852,0000.51%
Rock Springs Capital Management LP 345,000$5,465,0000.34%
SECTORAL ASSET MANAGEMENT INC 168,140$2,663,0000.26%
FORMULA GROWTH LTD 62,213$985,0000.22%
MENTA CAPITAL LLC 111,915$1,773,0000.17%
View complete list of INTERSECT ENT INC shareholders